Abstract
FFA1 (GPR40) is a new target for treatment of type 2 diabetes. We recently identified the potent FFA1 agonist TUG-469 (5). Inspired by the structurally related TAK-875, we explored the effects of a mesylpropoxy appendage on 5. The appendage significantly lowers lipophilicity and improves metabolic stability while preserving potency, resulting in discovery of the potent FFA1 agonist 13.
Original language | English |
---|---|
Journal | Journal of Medicinal Chemistry |
Volume | 55 |
Issue number | 14 |
Pages (from-to) | 6624-6628 |
Number of pages | 5 |
ISSN | 0022-2623 |
DOIs | |
Publication status | Published - 2012 |
Externally published | Yes |